Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Read more about Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy Read more about Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
MarginProbe® System U.S. Post-Approval Study Read more about MarginProbe® System U.S. Post-Approval Study
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Read more about A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
Registry of Guardant360® Use and Outcomes In People With Advanced Cancer Read more about Registry of Guardant360® Use and Outcomes In People With Advanced Cancer
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) Read more about A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection Read more about To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer Read more about Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer Read more about Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer Read more about VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer